Interval breast cancers are not biologically distinct—Just more difficult to diagnose
- 31 December 1994
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 168 (6) , 538-542
- https://doi.org/10.1016/s0002-9610(05)80118-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancersCancer, 1993
- Interval carcinomas in the Malmö Mammographic Screening Trial: radiographic appearance and prognostic considerations.American Journal of Roentgenology, 1992
- Abnormalp53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-upVirchows Archiv, 1992
- CA-15.3, TPA and MCA as markers for breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Gross cystic disease fluid protein-15 as a marker for breast cancer: Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbuminHuman Pathology, 1989
- The impact of breast cancer screening on survival: A 5- to 10-year follow-up studyCancer, 1986
- Carbohydrate Antigenic Determinant (CA 19–9) and Other Tumor Markers in Gastrointestinal MalignanciesDigestion, 1985
- Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast TumorsHybridoma, 1984
- Screening for Breast CancerAnnals of Surgery, 1977
- Risk for breast cancer development determined by mammographic parenchymal patternCancer, 1976